Calithera Biosciences

Calithera Biosciences is a clinical-stage biopharmaceutical company based in South San Francisco, California. With a team of 29 employees, the company focuses on groundbreaking research and development within the field of targeted cancer therapies. Calithera Biosciences has generated $9.8 million in revenue. Calithera Biosciences is dedicated to developing innovative targeted therapies that disrupt metabolic pathways within tumor cells. Their approach aims to preferentially starve these cells while enhancing the effectiveness of immune cells in fighting cancer. The company's pipeline includes several first-in-clinic, oral therapeutics designed to provide new treatment options for patients battling cancer and other life-threatening diseases. Calithera Biosciences distinguishes itself through its commitment to rigorous scientific methods and a deep-seated passion for improving patient outcomes. The company's research is driven by a desire to develop therapies that meaningfully expand treatment options and offer hope to those affected by debilitating diseases. For more information about Calithera Biosciences and its groundbreaking work, please visit their website at calithera.com.